Wellington Management Group LLP 13D/13G Filings for UroGen Pharma Ltd. (URGN)

Wellington Management Group LLP 13D and 13G filings for UroGen Pharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-04
09:12 am
Sale
2021-12-3113GUroGen Pharma Ltd.
URGN
Wellington Management Group LLP238,008
1.060%
-1,602,629decrease
(-87.07%)
Filing
2021-02-03
1:13 pm
Purchase
2020-12-3113GUroGen Pharma Ltd.
URGN
Wellington Management Group LLP1,840,637
8.330%
550,040increase
(+42.62%)
Filing